OpenBilldrug price receipt

NADAC week of 2026-10-14

BISOPROLOL-HYDROCHLOROTHIAZIDE 10-6.25 MG TAB

For 30 tablets

Pharmacies pay

$6.28 filed

30 × $0.20936 per EA

CMS NADAC · nadac-national-average-drug-acquisition-cost-20261014.csv · eff. 2026-09-23 · as of 2026-10-14 · retrieved 2026-10-17

Medicare Part D paid

$10.29 filed

30 × $0.34294 per EA, Part D average

Medicare's price is not your price.

Medicare Part D · DSD_PTD_RY26_P04_V10_DY24_BGM.csv · eff. 2024-01-01 to 2024-12-31 · as of 2026-06-25 · retrieved 2026-10-18


The spread

1.6× estimated

Medicare paid 1.6× what pharmacies pay.

Part D averages every strength and form sold under “Bisoprolol-Hydrochlorothiazide” / “Bisoprolol/Hydrochlorothiazide” into one figure, so it is not specific to this NDC.

OpenBill calculation · DSD_PTD_RY26_P04_V10_DY24_BGM.csv + nadac-national-average-drug-acquisition-cost-20261014.csv · NADAC eff. 2026-09-23 (file of 2026-10-14, retrieved 2026-10-17) · Part D 2024-01-01 to 2024-12-31 (file of 2026-06-25, retrieved 2026-10-18)

Cost-plus estimate

$12.22 estimated

$6.28 + $0.94 (15%) + $5.00 fee per fill = $12.22

This is a model, not a price any pharmacy quoted. Shipping is not included. How it is worked out

OpenBill calculation · nadac-national-average-drug-acquisition-cost-20261014.csv · NADAC eff. 2026-09-23 (file of 2026-10-14, retrieved 2026-10-17)

Open the interactive card Change the quantity, type what you were charged, and see every record in full.

What it is

BISOPROLOL-HYDROCHLOROTHIAZIDE 10-6.25 MG TAB is how the CMS NADAC file names this product. The FDA NDC Directory lists it as bisoprolol fumarate and hydrochlorothiazide.

FDA gives its dosage form as “tablet, film coated” and “tablet” and its route as oral.

FDA lists 7 labelers (the companies named on the label) for its NDCs, among them Teva Pharmaceuticals USA, Inc., Mylan Pharmaceuticals Inc. and Unichem Pharmaceuticals (USA), Inc.

FDA lists it under 2 Established Pharmacologic Classes: beta-Adrenergic Blocker and Thiazide Diuretic.

The NADAC file of 2026-10-14 prices it under 16 NDCs (National Drug Codes).

NADAC classes it as a generic drug (rate-setting class G), and does not mark it as sold over the counter.

What pharmacies pay

Pharmacies pay $6.28 for 30 tablets (30 × $0.20936 per EA, rounded to the cent), by the CMS NADAC file of 2026-10-14; that price took effect on 2026-09-23. That is what pharmacies pay their suppliers, not what they charge you.

NADAC’s explanation codes for it: 1, calculated from the most recently completed pharmacy survey; 6, the CMS Covered Outpatient Drug Product File S/I/N drug category was not applied when grouping drugs for the calculation.

The 7 labelers

LabelerNDCsPharmacies pay per unit
Edenbridge Pharmaceuticals LLC.3$0.20936 per EA filed
GLENMARK PHARMACEUTICALS INC., USA3$0.20936 per EA filed
Unichem Pharmaceuticals (USA), Inc.3$0.20936 per EA filed
Viona Pharmaceuticals Inc3$0.20936 per EA filed
ANI Pharmaceuticals, Inc.2$0.20936 per EA filed
Mylan Pharmaceuticals Inc.1$0.20936 per EA filed
Teva Pharmaceuticals USA, Inc.1$0.20936 per EA filed
All 16 NDCs, with labeler and price
  • 00093-3243-56 · Teva Pharmaceuticals USA, Inc. · $0.20936 per EA · eff. 2026-09-23 filed
  • 00378-0505-01 · Mylan Pharmaceuticals Inc. · $0.20936 per EA · eff. 2026-09-23 filed
  • 29300-0189-01 · Unichem Pharmaceuticals (USA), Inc. · $0.20936 per EA · eff. 2026-09-23 filed
  • 29300-0189-05 · Unichem Pharmaceuticals (USA), Inc. · $0.20936 per EA · eff. 2026-09-23 filed
  • 29300-0189-13 · Unichem Pharmaceuticals (USA), Inc. · $0.20936 per EA · eff. 2026-09-23 filed
  • 42799-0922-01 · Edenbridge Pharmaceuticals LLC. · $0.20936 per EA · eff. 2026-09-23 filed
  • 42799-0922-02 · Edenbridge Pharmaceuticals LLC. · $0.20936 per EA · eff. 2026-09-23 filed
  • 42799-0922-30 · Edenbridge Pharmaceuticals LLC. · $0.20936 per EA · eff. 2026-09-23 filed
  • 68462-0880-01 · GLENMARK PHARMACEUTICALS INC., USA · $0.20936 per EA · eff. 2026-09-23 filed
  • 68462-0880-05 · GLENMARK PHARMACEUTICALS INC., USA · $0.20936 per EA · eff. 2026-09-23 filed
  • 68462-0880-30 · GLENMARK PHARMACEUTICALS INC., USA · $0.20936 per EA · eff. 2026-09-23 filed
  • 70954-0414-10 · ANI Pharmaceuticals, Inc. · $0.20936 per EA · eff. 2026-09-23 filed
  • 70954-0414-30 · ANI Pharmaceuticals, Inc. · $0.20936 per EA · eff. 2026-09-23 filed
  • 72578-0115-01 · Viona Pharmaceuticals Inc · $0.20936 per EA · eff. 2026-09-23 filed
  • 72578-0115-05 · Viona Pharmaceuticals Inc · $0.20936 per EA · eff. 2026-09-23 filed
  • 72578-0115-06 · Viona Pharmaceuticals Inc · $0.20936 per EA · eff. 2026-09-23 filed

Other strengths, forms and brands

2 other products in the NADAC file share the FDA nonproprietary name bisoprolol fumarate and hydrochlorothiazide with BISOPROLOL-HYDROCHLOROTHIAZIDE 10-6.25 MG TAB.

ProductPharmacies pay per unitMedicare per unit
BISOPROLOL-HYDROCHLOROTHIAZIDE 2.5-6.25 MG TB
generic · tablet, film coated / tablet
$0.21329 per EA filed
eff. 2026-09-23
$0.34294 per EA filed
Part D 2024 average
BISOPROLOL-HYDROCHLOROTHIAZIDE 5-6.25 MG TAB
generic · tablet, film coated / tablet
$0.22026 per EA filed
eff. 2026-09-23
$0.34294 per EA filed
Part D 2024 average
BISOPROLOL-HYDROCHLOROTHIAZIDE 10-6.25 MG TAB this page
generic · tablet, film coated / tablet
$0.20936 per EA filed
eff. 2026-09-23
$0.34294 per EA filed
Part D 2024 average

Part D is one average per brand and generic name, over every strength and form.

CMS NADAC · nadac-national-average-drug-acquisition-cost-20261014.csv · eff. 2026-09-23 · as of 2026-10-14 · retrieved 2026-10-17

Medicare Part D · DSD_PTD_RY26_P04_V10_DY24_BGM.csv · eff. 2024-01-01 to 2024-12-31 · as of 2026-06-25 · retrieved 2026-10-18

Compared with its class

The middle of its 16 NDCs’ NADAC prices is $0.20936 per EA filed.

Of the 76 other products in FDA’s beta-Adrenergic Blocker class priced per EA, 43 have a higher middle NADAC price and 33 a lower one. The one in the middle is NADOLOL 40 MG TABLET, at $0.26544 per EA filed (eff. 2026-09-23).

Of the 68 other products in FDA’s Thiazide Diuretic class priced per EA, 44 have a higher middle NADAC price and 24 a lower one. The one in the middle is AMILORIDE HCL-HYDROCHLOROTHIAZIDE 5-50 MG TAB, at $0.44985 per EA filed (eff. 2026-09-23).

Prices are compared per unit, whatever the strength or dose, and a class is not a list of substitutes.

CMS NADAC · nadac-national-average-drug-acquisition-cost-20261014.csv · eff. 2026-09-23 · as of 2026-10-14 · retrieved 2026-10-17

What Medicare paid

Medicare Part D paid $10.29 for 30 tablets, at an average of $0.34294 per EA in 2024 (2024-01-01 to 2024-12-31) for “Bisoprolol-Hydrochlorothiazide” and “Bisoprolol/Hydrochlorothiazide”, every strength and form sold under that name together (Medicare Part D Spending by Drug, file of 2026-06-25).

That average covers 568,266 Part D claims (fills, including refills) for 2024-01-01 to 2024-12-31, across every maker, strength and form under the name.

Medicare's price is not your price.

What to ask at the counter

None of these figures is your price: what you pay depends on your pharmacy, your insurance, coupons and discounts.

Questions

Why is the comparison with Medicare for BISOPROLOL-HYDROCHLOROTHIAZIDE 10-6.25 MG TAB labelled estimated?
Beyond what the card shows, the records give these reasons: The Part D figure covers 2024-01-01 to 2024-12-31; the NADAC price is from the file of 2026-10-14. Part D spending basis, as the Part D record states it: Part D 2024 average spend per dosage unit for Bisoprolol-Hydrochlorothiazide / Bisoprolol/Hydrochlorothiazide: all makers, strengths, forms and routes combined, claim-weighted; gross cost incl. dispensing fees and patient pay, before rebates. Unit taken as NADAC's EA. Joined on generic name.